Literature DB >> 11302950

Rational dosing of azathioprine and 6-mercaptopurine.

W J Sandborn1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11302950      PMCID: PMC1728293          DOI: 10.1136/gut.48.5.591

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  26 in total

1.  Safe treatment of thiopurine S-methyltransferase deficient Crohn's disease patients with azathioprine.

Authors:  B A Kaskas; E Louis; U Hindorf; E Schaeffeler; J Deflandre; F Graepler; K Schmiegelow; M Gregor; U M Zanger; M Eichelbaum; M Schwab
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

2.  Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.

Authors:  M V Relling; E E Gardner; W J Sandborn; K Schmiegelow; C-H Pui; S W Yee; C M Stein; M Carrillo; W E Evans; T E Klein
Journal:  Clin Pharmacol Ther       Date:  2011-01-26       Impact factor: 6.875

3.  Thiopurine metabolites and the role of thiopurine methyltransferase activity in inflammatory bowel disease.

Authors:  A Qasim; M Buckley; C A O' Morain
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

4.  Prolonged remission of severe Crohn's disease after fever and leukopenia caused by 6-mercaptopurine.

Authors:  Efrat Z Lobel; Burton I Korelitz; Katherine Vakher; Georgia Panagopoulos
Journal:  Dig Dis Sci       Date:  2004-02       Impact factor: 3.199

5.  Crohn's disease or abdominal tuberculosis?

Authors: 
Journal:  Gut       Date:  2007-12       Impact factor: 23.059

6.  European evidence based consensus on the diagnosis and management of Crohn's disease: current management.

Authors:  S P L Travis; E F Stange; M Lémann; T Oresland; Y Chowers; A Forbes; G D'Haens; G Kitis; A Cortot; C Prantera; P Marteau; J-F Colombel; P Gionchetti; Y Bouhnik; E Tiret; J Kroesen; M Starlinger; N J Mortensen
Journal:  Gut       Date:  2006-03       Impact factor: 23.059

7.  Pretreatment determination of TPMT--state of the art in clinical practice.

Authors:  A Teml; E Schaeffeler; M Schwab
Journal:  Eur J Clin Pharmacol       Date:  2009-02-07       Impact factor: 2.953

8.  Leukopenia predicts remission in patients with inflammatory bowel disease and Behcet's disease on thiopurine maintenance.

Authors:  Mi Sung Park; Dong Hyun Kim; Duk Hwan Kim; Soo Jung Park; Sung Pil Hong; Tae Il Kim; Won Ho Kim; Jae Hee Cheon
Journal:  Dig Dis Sci       Date:  2014-09-20       Impact factor: 3.199

Review 9.  Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Inflammatory Bowel Disease.

Authors:  Luc J J Derijks; Dennis R Wong; Daniel W Hommes; Adriaan A van Bodegraven
Journal:  Clin Pharmacokinet       Date:  2018-09       Impact factor: 6.447

Review 10.  Pharmacogenetics in inflammatory bowel disease.

Authors:  Marie Pierik; Paul Rutgeerts; Robert Vlietinck; Severine Vermeire
Journal:  World J Gastroenterol       Date:  2006-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.